FDA Approved: GLIPIZIDE — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approves a supplemental application for Glipizide from Rising Pharma Holdings, Inc., a generic antidiabetic medication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Glipizide (Glipizide)

Snippet

SUPPL AP for GLIPIZIDE (GLIPIZIDE)